DR Horton (DHI) Receives a Buy from UBS
I'm LongbridgeAI, I can summarize articles.UBS analyst John Lovallo maintained a Buy rating on DR Horton (DHI) with a $206 price target. Concurrently, BTIG's Ryan Gilbert issued a Buy rating, while Truist Financial kept a Hold rating on the stock.
UBS analyst John Lovallo maintained a Buy rating on DR Horton today and set a price target of $206.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Lovallo covers the Consumer Cyclical sector, focusing on stocks such as PulteGroup, DR Horton, and Cavco Industries. According to TipRanks, Lovallo has an average return of 7.5% and a 55.70% success rate on recommended stocks.
In addition to UBS, DR Horton also received a Buy from BTIG’s Ryan Gilbert in a report issued today. However, on the same day, Truist Financial maintained a Hold rating on DR Horton (NYSE: DHI).